2020 ANZSN ASM Supporters (OLD)

The ANZSN ASM would simply not be possible without the ongoing and dedicated support
of our industry partners.

Click on the logos below to find out more about the organisation’s
whose sponsorship is helping to bring your annual industry meeting to life.


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory.

Read More

The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Show Less

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure, caring for more than 347,000 patients in our global network of more than 4,000 dialysis clinics.  Operating 45 production sites in more than 20 countries, including local Australian manufacturing facilities in New South Wales and Victoria, we produce dialysis machines, dialyzers, therapeutic treatment chairs and related disposables to support renal care in hospitals, home patients and dialysis clinics across Australia and New Zealand.

Read More

Our Global Research and Development division enables us to focus and develop products efficiently – promoting the exchange of knowledge and technology between our regions. Fresenius focuses on innovative products, and we’re continuously improving our dialysis treatments to enhance our patients’ experiences with our portfolio encompassing a comprehensive range of high-quality health care products and services for the chronic environment and the critical care setting.

Fresenius Medical Care provides direct patient care through our dedicated Fresenius Kidney Care Dialysis Clinics. As the largest private provider of dialysis care in Australia, our nursing and support staff help people with chronic kidney disease and end stage renal disease live a fuller, more active and vibrant life.

Show Less


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Read More

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Twentynine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines.

Founded in 1896, the Roche Group is headquartered in Basel, Switzerland, and is active in over 100 countries. In 2016 Roche employed more than 94,000 people worldwide and invested CHF 9.9 billion in research and development, including almost AUD 37 million in pharmaceuticals in Australia. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices.

Roche’s pharmaceutical division in Australia is dedicated to the clinical development, registration, sales, marketing and distribution of innovative pharmaceutical medicines. Australian patients have access to about 40 Roche medicines, and the company is the leading provider of cancer medicines in Australia by sales.

Show Less


Transplantation Theme Sponsor


General Nephrology Theme Sponsor



KHA Clinical Science Award and the 2020 ANZSN and KHA Environmental Research Award

Recent Comments